Stroke and transient ischaemic attack in over 16s: diagnosis and initial management

use CE-marked devices for their intended purpose where possible. See MHRA's guidance on off-label use of a medical device for further information. Recommendation 1.4.12 There may be a subgroup of people for whom the risk of venous thromboembolism outweighs the risk of haemorrhagic transformation. People considered to be at particularly high risk of venous thromboembolism include anyone with complete paralysis of the leg, a previous history of venous thromboembolism, dehydration or comorbidities (such as malignant disease), or who is a current or recent smoker. Such people should be kept under regular review if they are given prophylactic anticoagulation. Recommendation 1.4.15 There was insufficient evidence to support any recommendation on the safety and efficacy of anticoagulants versus antiplatelets for the treatment of people with acute ischaemic stroke associated with antiphospholipid syndrome. Recommendation 1.4.21 The consensus of the committee is that it would be safe to start statins after 48 hours. Recommendations for research As part of the 2022 update, the guideline committee made an additional 2 recommendations for research. As part of the 2019 update, the guideline committee retained the recommendations for research on avoidance of aspiration pneumonia, aspirin and anticoagulant treatment for acute ischaemic stroke, aspirin treatment in acute ischaemic
